This TforG Healthcare Market review report for the Kingdom of Saudi Arabia includes numerical and written analysis on the socioeconomic and macroeconomic context and outlook, the healthcare system, and the latest healthcare reforms. Moreover, an extensive chapter is dedicated to the markets for capital equipment, medical devices, disposables and pharmaceuticals.
The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
Economic Outlook: - GDP annual growth was at 8.4 percent in 2011, and has since then dwindled to 4.4 percent in 2015. GDP growth rates are expected to increase slightly to about 4.5 percent by 2017. -Official unemployment figures are relatively low at 5.7 percent, however this percentage increases when one looks specifically at the population 29 years and younger (unemployment rates are highest in this age bracket). -Inflation in Saudi Arabia has declined slightly from 3.6 percent in 2014 to 3.5 percent in 2015. -In an effort to diversify the economy and diminish the kingdom’s dependence on oil, the local authorities have put a series of facilities, subsidies and support systems in place with the goal of stimulating industrial development (e.g. Saudi Industrial Investment Fund). -According to KSA’s Ministry of Finance, this year’s total government expenditure was budgeted at € 211 bln, revenues were estimated at € 175.4 bln and a fiscal deficit of about € 35.5 bln is anticipated.
The Healthcare System: -Like most countries in the GCC, KSA is currently going through an era of both epidemiological and demographic changes that are resulting increased incidence levels of chronic illness and higher demands for quality healthcare services. -Healthcare expenditures in KSA represented about 4.5 percent of the kingdom’s GDP in 2014. This amount is expected to increase slightly to 4.6 by the end of 2015. -About, 70 percent of KSA’s healthcare expenditures are funded through public sources while the latter 40 percent stems from private sources. -Of the total government spending budget this year, about 18.6 percent has been allocated for healthcare. This comes out to a healthcare budget of about € 38.8 bln for 2015. - Healthcare budget allocation has increased by about 48 percent compared to 2014.
Reforms: Reforms will center around the following: - Reducing capacity gaps - Improving the quality of care - Attracting and retaining a qualified staff - Expanding the role of the private sector in healthcare
The Markets: -KSA’s healthcare market is considered the largest of all GCC countries, with an estimated € 18 bln spent annually in this sector. -Of this expenditure, the MOH is responsible for about 60 percent, other government organizations are responsible for about 19 percent, and the private sector accounts for the remaining 21 percent. Annual expenditures on medical devices account for about 15 percent of the budget, while pharmaceuticals account for about 25 percent. -Increases in the percentage of insured patients will increase demand for healthcare services, especially in the private sector. -The government is actively encouraging private sector growth and public/private partnerships (PPP), creating a series of opportunities for private investors (e.g. providing interest-free loans to private entities). -Annual expenditures on medical devices account for about 15 percent of the budget, while pharmaceuticals account for about 25 percent.
Reasons to buy: – Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry – Relevant healthcare reforms – Written and numerical analysis on important healthcare indicators (eg.: acute care data, critical care data, anesthesia data, emergency data, healthcare professionals) – Regularly updates, at least once year – Every update published by TforG within 6 months after your purchase will be made available to you – Global coverage, available for + 40 countries – Unique insight into the socio-economic dynamics, and analysis of their effect on healthcare systems
Table Of Contents
Review of the Healthcare System and Medical Device Market in The Kingdom of Saudi Arabia - report 1.0 Executive Summary 2.0 Socioeconomic Outlook 2.1 Socioeconomic Context 2.2 Macroeconomics 2.3 Table 1.1 - Macroeconomics 2.4 Economic Outlook 3.0 The Saudi Arabian Healthcare System 3.1 Introduction 3.2 Healthcare Status 3.3 Table 2.1 - Healthcare 3.4 Healthcare Expenditures 3.5 The Organization 3.6 Kingdom Level 3.7 Regional Level 3.8 Diagram 2.1 - Healthcare Organization 3.9 Primary Care 3.10 Secondary Care 3.11 Table 2.2 - Secondary Care 3.12 Healthcare Insurance 3.13 Healthcare Financing 3.14 Diagram 2.2 - Financial Flow 3.15 Private versus Public 4.0 Healthcare Reforms 4.1 Current Challenges 4.2 Recent Reforms 4.3 Hospital Operations and Priorities 5.0 The Markets 5.1 Market Outlook 5.2 Purchase Processes and Decision-Making 5.3 Pharmaceuticals 5.4 Capital Equipment and Medical Devices 5.5 Medical Disposables 5.6 Opportunities 6.0 Country Overview 6.1 Demographics, Macroeconomics and Healthcare 7.0 National Care Provision Data 7.1 Acute Care Data 7.2 Critical Care 7.3 Anesthesia 7.4 Emergency 7.5 Hospital Services Data 7.6 Healthcare Professionals 8.0 The TforG Methodology 8.1 Primary Research 8.2 Secondary Research 8.3 Our Experience
Companies Mentioned Tawuniya, Medgulf, Bupa, Sanofi-Aventis, Pfizer, Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Alshifa Medical Syringes Manufacturing Co, Jamjoon Hospital Supply (JHS).